159 related articles for article (PubMed ID: 20630400)
1. The etiology of anemia in heart failure. Preface.
Agarwal AK; Katz SD; Singh AK
Heart Fail Clin; 2010 Jul; 6(3):xvii-xviii. PubMed ID: 20630400
[No Abstract] [Full Text] [Related]
2. Erythropoietin and heart failure: the end of a promise?
Kleijn L; Westenbrink BD; van der Meer P
Eur J Heart Fail; 2013 May; 15(5):479-81. PubMed ID: 23558218
[No Abstract] [Full Text] [Related]
3. Anemia in heart failure: an overview of current concepts.
von Haehling S; Jankowska EA; Ponikowski P; Anker SD
Future Cardiol; 2011 Jan; 7(1):119-29. PubMed ID: 21174515
[TBL] [Abstract][Full Text] [Related]
4. Erythropoiesis-stimulating agents in kidney and cardiac disease.
Fluck R
Br J Hosp Med (Lond); 2006 Oct; 67(10):533-7. PubMed ID: 17069130
[No Abstract] [Full Text] [Related]
5. Darbapoetin alfa does not help adults with heart failure and anaemia.
BMJ; 2013 Mar; 346():f1626. PubMed ID: 23487165
[No Abstract] [Full Text] [Related]
6. Anemia in chronic heart failure: should we treat it and how?
Komajda M
J Am Coll Cardiol; 2007 Feb; 49(7):763-4. PubMed ID: 17306704
[No Abstract] [Full Text] [Related]
7. Anemia in chronic heart failure.
Drakos SG; Anastasiou-Nana MI; Malliaras KG; Nanas JN
Congest Heart Fail; 2009; 15(2):87-92. PubMed ID: 19379455
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin in kidney disease and type 2 diabetes.
Thum T; Kalantar-Zadeh K; Anker SD
N Engl J Med; 2011 Jan; 364(4):384-5; author reply 385-6. PubMed ID: 21268744
[No Abstract] [Full Text] [Related]
9. Use of erythropoietin in heart failure management.
Caiola K; Cheng JW
Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385
[TBL] [Abstract][Full Text] [Related]
10. Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction.
Howlett JG
Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):199-208. PubMed ID: 18248274
[TBL] [Abstract][Full Text] [Related]
11. Anemia in chronic heart failure: can we treat? What to treat?
von Haehling S; Anker MS; Jankowska EA; Ponikowski P; Anker SD
Heart Fail Rev; 2012 Mar; 17(2):203-10. PubMed ID: 21979835
[TBL] [Abstract][Full Text] [Related]
12. Haemodilution is a mechanism of anaemia in patients with heart failure: reply.
Westenbrink BD; Kleijn L; van der Meer P
Eur J Heart Fail; 2013 Sep; 15(9):1075-6. PubMed ID: 23960086
[No Abstract] [Full Text] [Related]
13. [Anemia as complication of chronic heart failure: prevalence, treatment, prognosis].
Tereshchenko SN; Atroshchenko ES; Uskach TM; Kudinova AA; Riabinina MN
Ter Arkh; 2008; 80(9):90-5. PubMed ID: 19555048
[No Abstract] [Full Text] [Related]
14. Erythropoiesis-stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness?
Messori A; Fadda V; Maratea D; Trippoli S
Eur J Heart Fail; 2013 Aug; 15(8):944-5. PubMed ID: 23884182
[No Abstract] [Full Text] [Related]
15. Management of anemia in heart failure.
Stamos TD; Silver MA
Curr Opin Cardiol; 2010 Mar; 25(2):148-54. PubMed ID: 19996965
[TBL] [Abstract][Full Text] [Related]
16. Against TREATing all patients alike: lessons from an FDA Advisory Committee Meeting.
Winkelmayer WC
J Am Soc Nephrol; 2011 Jan; 22(1):1-2. PubMed ID: 21164031
[No Abstract] [Full Text] [Related]
17. Erythropoietin: high profile, high scrutiny.
Crawford J
J Clin Oncol; 2007 Mar; 25(9):1021-3. PubMed ID: 17312331
[No Abstract] [Full Text] [Related]
18. Haemodilution is a mechanism of anaemia in patients with heart failure.
Prakash ES
Eur J Heart Fail; 2013 Sep; 15(9):1074. PubMed ID: 23883650
[No Abstract] [Full Text] [Related]
19. Treatment of anemia with darbepoetin alfa in heart failure.
Abraham WT; Anand IS; Klapholz M; Ponikowski P; Scarlata D; Wasserman SM; van Veldhuisen DJ
Congest Heart Fail; 2010; 16(3):87-95. PubMed ID: 20557327
[TBL] [Abstract][Full Text] [Related]
20. Does TREAT give the boot to ESAs in the treatment of CKD anemia?
Singh AK
J Am Soc Nephrol; 2010 Jan; 21(1):2-6. PubMed ID: 20035034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
